CFTC advisory committee meeting on prediction markets turns contentious
A Commodity Futures Trading Commission (CFTC) Innovation Advisory Committee meeting on Thursday, August 20, grew heated as members raised concerns that prediction markets could be susceptible to insider trading and worried over markets listed without the agency's prior approval. The committee includes more than 30 members with representatives from Robinhood, Nasdaq, and CME Group. CME Group's CEO clashed with the CFTC chair over how prediction markets should be overseen. The dispute comes as prediction market trading startups grow into multibillion-dollar businesses.
The CFTC's own innovation panel is now openly divided on how to police the sector it licenses. For Kalshi and Polymarket, a committee that cannot agree on basic oversight vocabulary makes every pending enforcement action harder to predict. CME Group's public clash with the chair signals that incumbent exchanges will push for stricter rules that favor their existing compliance infrastructure.
The insider-trading specter raised Thursday gives Congress a ready narrative for pending legislation that would ban sports event contracts outright. Platforms must now prepare for rulemaking that may emerge from a fractured committee with no consensus timeline. The multibillion-dollar scale of these startups means the CFTC cannot delay indefinitely without political blowback from both sides. A chair bypassing her own advisory panel to write conservative guidance would alienate the fintech voices the agency recruited.
Follows a CFTC warning just days earlier that Kalshi and Polymarket must strip gambling-style odds formatting from their sites, making this the second consecutive federal action to treat event-contract presentation as a regulatory frontier.